BioLine Rx Stock (NASDAQ: BLRX) stock price, news, charts, stock research, profile.
You can purchase shares of BioLine Rx (NASDAQ:BLRX) through any online brokerage.
Other companies in BioLine Rx’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), OncoCyte (NASDAQ:OCX) and Gain Therapeutics (NASDAQ:GANX).
BioLine Rx has a consensus price target of $9.00.
The stock price for BioLine Rx (NASDAQ: BLRX) is $0.336 last updated November 21, 2024 at 2:13 PM EST.
There are no upcoming dividends for BioLine Rx.
BioLine Rx’s Q3 earnings are confirmed for Monday, November 25, 2024.
There is no upcoming split for BioLine Rx.
BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.